Carfilzomib
| Carfilzomib | |
|---|---|
| Term | Carfilzomib |
| Short definition | Carfilzomib - (pronounced) (kar-FIL-zoh-mib) drug used alone or with other drugs to treat adults with multiple myeloma that has come back or not improved after treatment with one or more other therapies. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Carfilzomib - (pronounced) (kar-FIL-zoh-mib) drug used alone or with other drugs to treat adults with multiple myeloma that has come back or not improved after treatment with one or more other therapies. It is also being studied in the treatment of other types of cancer. Carfilzomib blocks the action of enzymes called proteasomes, which can help stop cancer cells from growing and kill them. It's a type of proteasome inhibitor. Also called Kyprolis
External links
- Medical encyclopedia article on Carfilzomib
- Wikipedia's article - Carfilzomib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski